© 2001 European Society of Cardiology
Torsades de pointes caused by Mibefradil
Unfallkrankenhaus Berlin, Department of Internal Medicine Warener Strasse 7, D-12683 Berlin, Germany
* Corresponding author. Tel.: +49-30-5681-3601; fax: +49-30-5681-3603. E-mail address: franz-xaverk{at}ukb.de (F.X. Kleber)
| Abstract |
|---|
We report a case of symptomatic Torsades de pointes due to QTc prolongation by Mibefradil, which potentially explains unexpected deaths related to this drug. Multiple episodes of Torsades de pointes were documented in a 76-year-old woman with significant QTc prolongation of 0.53 s. After discontinuation of Mibefradil QTc intervals normalized and no further ventricular tachyarrythmias were observed. We conclude that Mibefradil can cause QTc prolongation and life threatening ventricular dysrhythmias.
Key Words: Mibefradil Calcium channel blocker Torsades de pointes Ventricular tachycardias
Received February 2, 2001; Revised February 2, 2001; Accepted April 26, 2001